Cargando…
Genotype-Based Ancestral Background Consistently Predicts Efficacy and Side Effects across Treatments in CATIE and STAR*D
Only a subset of patients will typically respond to any given prescribed drug. The time it takes clinicians to declare a treatment ineffective leaves the patient in an impaired state and at unnecessary risk for adverse drug effects. Thus, diagnostic tests robustly predicting the most effective and s...
Autores principales: | Adkins, Daniel E., Souza, Renan P., Åberg, Karolina, Clark, Shaunna L., McClay, Joseph L., Sullivan, Patrick F., van den Oord, Edwin J. C. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566192/ https://www.ncbi.nlm.nih.gov/pubmed/23405125 http://dx.doi.org/10.1371/journal.pone.0055239 |
Ejemplares similares
-
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR(*)D
por: Adkins, D E, et al.
Publicado: (2012) -
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
por: Adkins, Daniel E., et al.
Publicado: (2010) -
High density methylation QTL analysis in human blood via next-generation sequencing of the methylated genomic DNA fraction
por: McClay, Joseph L., et al.
Publicado: (2015) -
Genomewide Pharmacogenomic Analysis of Response to Treatment with Antipsychotics
por: McClay, Joseph L., et al.
Publicado: (2009) -
Estimation of CpG coverage in whole methylome next-generation sequencing studies
por: van den Oord, Edwin JCG, et al.
Publicado: (2013)